All content for CReATe Podcast is the property of CReATe Consortium and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.
Psilocybin is a psychedelic chemical derived from mushrooms. It is under study for mood problems in people with ALS. Here we review its plausible mechanisms for slowing ALS progression. But there are no data from preclinical models, trials or case reports that currently support this benefit. And there can be serious risks to using this chemical.
CReATe Podcast
CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.
